2 results
Approved WMOCompleted
To obtain histopathology from liver lesions, visible on MRI but which cannot be biopsied with transabdominal ultrasound, using MR-guided biopsy.
Approved WMORecruiting
The primary objective is to determine if the addition of daratumumab to VRd will prolong PFS defined as the time from the date of randomization to the date of disease progression (assessed by International Myeloma Working Group [IMWG] criteria) or…